ResMed (RMD) Revenue — Quarter Ended Mar 31, 2025
Revenue increased compared to the prior quarter and rose sharply versus the same quarter last year. The sequential gain was modest, while the year-over-year growth was more pronounced.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q3
Revenue increased compared to the prior quarter and rose sharply versus the same quarter last year. The sequential gain was modest, while the year-over-year growth was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.3B
Revenue reported for this quarter.
Quarter-over-quarter
+0.8%
Change from the immediately preceding quarter.
Year-over-year
+7.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $1.2B | +9.0% |
| Sep 30, 2024 | $1.2B | +11.1% |
| Dec 31, 2024 | $1.3B | +10.3% |
| Mar 31, 2025 | $1.3B | +7.9% |
Revenue performance
The reported revenue for the quarter was higher than the immediately preceding quarter, continuing an upward trend. Compared with the same quarter one year earlier, revenue showed a solid increase.
Quarterly comparison
Sequentially, revenue edged up from the prior quarter. On a year-over-year basis, revenue grew at a faster pace than the sequential change, reflecting stronger demand compared to the same period last year.
What to watch
Monitor whether the sequential revenue growth rate can sustain or accelerate in the coming quarters.